# OnCo record paper-takahashi-trastuzumab-docetaxel-salivary-duct-jco-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-takahashi-trastuzumab-docetaxel-salivary-duct-jco-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-takahashi-trastuzumab-docetaxel-salivary-duct-jco-2019" ;
  schema:name "Phase 2 trial of trastuzumab and docetaxel in HER2-positive salivary duct carcinoma"@en ;
  schema:description "In HER2-positive salivary duct carcinoma, an aggressive salivary cancer resembling breast cancer, trastuzumab plus docetaxel shrank tumours in 70 percent of patients, establishing HER2 testing and targeting in the disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-takahashi-trastuzumab-docetaxel-salivary-duct-jco-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.18.00545>, <https://pubmed.ncbi.nlm.nih.gov/30452336/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.18.00545> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Takahashi H, Tada Y, Saotome T, et al." ;
  onco:cancers <https://onco.cc/cancers/salivary-duct-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:journals <https://onco.cc/journals/jco/> .